It is known that most of the so-called’Kyobo Securities Kwang-cle Team’, which almost swept away the volume of purchase orders on the 18th, the first day of SK Bioscience’s listing, sold out most of them on the 19th.
SK Bioscience, which was listed on the KOSPI on the 18th, has succeeded in so-called’tasang’. yunhap news
Kyobo Securities “I don’t know who to buy or sell”
According to the Korea Exchange, on the 18th, Kyobo Securities was listed as the top-ranked counter for buying by SK Bioscience. The transaction volume reached 52,9814 shares (a purchase amount of 89.4 billion won). Nearly 70% of the total trading volume was wiped out at the Kyobo Securities window. On this day, SK Biosciences entered the stock market with so-called’dasang’ (double the public offering price and the upper limit after the initial price was formed), rising to 169,000 won.
Usually, if the stock price goes directly to the upper limit immediately after the listing date, the success of the purchase contract depends on who places the order quickly. The so-called’Kwang-cle’ (meaning to click crazy quickly) depends on whether the order is successful or not. It is estimated that the so-called’big-handed ant’ bought a large number of stocks using Kyobo Securities. Earlier, even on the first listing date of Kakao Games, the Kyobo Securities counter almost monopolized the purchase order.
On the 19th, the day after listing, Kyobo Securities is ranked 5th at the top sales window of SK Bioscience. The sell volume is about 660,000 shares. Around 9:30 a.m. that day, about 540,000 shares were sold. For this reason, some say that an investor who bought 530,000 shares through the Kyobo Securities window the previous day sold all of them and made a profit.
Although it is not possible to confirm the substance, if this investor, known as the Kyobo Securities Kwang-Kl Team, sold all of the relevant quantities, it would be a profit of 7.2 billion won in one day.
However, in the securities industry, it is said that “there is only speculation, and the contents cannot be verified.” An official from Kyobo Securities said, “We do not have the authority to check who placed the order in detail, so we cannot know who the buyers and sellers are.”
A brokerage manager who wanted to remain anonymous said, “I can’t know whether the subject is an individual or an institutional investor, and I can’t confirm the number of employees, and that I bought and sold all of the stocks yesterday. Even if I sold it, I don’t know the exact selling price. “It is also impossible to estimate.” He said, “Because it is a stock that has a lot of interest from investors, there seems to be a lot of speculative rumors.”
As of 12:23, on the second day of listing, SK Biosciences is trading at 174,000 won, up 2.96% from the previous day, and it has not reached’Daesang’ (the initial price doubled after the public offering doubled, and then the upper limit for two consecutive times). However, as a fierce single-hit battle took place, the trading volume as of this time exceeded 9.66 million shares, which was 11 times the previous day’s (876189 shares). The transaction value is also recording 1.75 trillion won.
Reporter Hwang Eui-young [email protected]
